Wang Junyuan Jerry has filed 13 insider transactions across 1 company since April 2024.
Most recent transaction: a sale of 56361 shares of Nuvation Bio Inc. ($NUVB) on November 11, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 11, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | S | Class A Common Stock | 56361 | $2.89 | 6,112,686.0000 | 0 | 0.91% | 0.00% |
| Sept. 4, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Class A Common Stock | 2543600 | $0.00 | 6,169,047.0000 | 0 | 70.16% | 0.00% |
| Sept. 4, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Class A Common Stock | 1695700 | $0.00 | 6,169,047.0000 | 0 | 37.91% | 0.00% |
| Sept. 3, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Series A Preferred Stock | 25436 | $0.00 | 25,436.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Series A Preferred Stock | 16957 | $0.00 | 16,957.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Warrants (Right to Buy) | 86471 | $0.00 | 144,118.0000 | 0 | 150.00% | 0.00% |
| Sept. 3, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Warrants (Right to Buy) | 57647 | $0.00 | 144,118.0000 | 0 | 66.67% | 0.00% |
| Sept. 4, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Series A Preferred Stock | 25436 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 4, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Series A Preferred Stock | 16957 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 9, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Class A Common Stock | 1378989 | $0.00 | 1,929,747.0000 | 0 | 250.38% | 0.00% |
| April 9, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Class A Common Stock | 550758 | $0.00 | 1,929,747.0000 | 0 | 39.94% | 0.00% |
| April 9, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Stock Option (Right to Buy) | 486669 | $0.00 | 486,669.0000 | 0 | 9999.99% | 0.00% |
| April 9, 2024 | Nuvation Bio Inc. | $NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Stock Option (Right to Buy) | 388299 | $0.00 | 388,299.0000 | 0 | 9999.99% | 0.00% |